What Problem We Solve

Problems Addressed by SpermoCheck Combo and Fertility Health Solutions

In the evolving world of reproductive health, both male and female fertility are often misunderstood, misdiagnosed, or inadequately addressed. SpermoCheck Combo and related products offer comprehensive solutions to these challenges, providing accurate, fast, and accessible fertility diagnostics for both men and women. Below are the critical problems these products solve:

1. Inconsistent and Delayed Fertility Diagnostics

Problem:
Traditional fertility tests, especially those for male fertility, are either subjective or require complex lab equipment and lengthy processing times. For women, ovarian reserve assessments, typically based on hormone testing, can be challenging to interpret and may not provide a complete picture of reproductive health.

Solution:

  • SpermoCheck Combo provides rapid, quantitative results for both sperm count and motility in males, overcoming the limitations of conventional semen analysis. This breakthrough is achieved through  a novel biomarker, enabling a quick and accurate fertility assessment.
  • For females, the AMH/FSH Combo tests enable reliable, at-home or clinic-based ovarian reserve and hormonal balance evaluations, helping women understand their fertility health with precision and ease.

Problem:
Infertility in men often goes undiagnosed or misclassified, with azoospermia (absence of sperm) being mistakenly assumed to be the same across all cases. It can be hard to distinguish between obstructive azoospermia (OA) and non-obstructive azoospermia (NOA) without expensive and invasive procedures.

Solution:

  • SpermoCheck Combo uses a novel biomarker to differentiate between OA and NOA with 100% specificity and 81% sensitivity. This enables precise diagnosis, reducing unnecessary procedures and helping tailor the most appropriate treatment options.

Problem:
Fertility tests, especially in males, can often require expensive laboratory tests and complex procedures, making fertility screening inaccessible for many people. Additionally, traditional male fertility testing may require multiple visits to the clinic or specialist.

Solution:

  • SpermoCheck Combo is designed for Point-of-Care Testing (POCT), offering a fast, affordable, and convenient way to assess both sperm count and motility with a simple sample of seminal plasma. Results are ready in just 10 minutes, ensuring quicker access to critical fertility data.
  • The AMH/FSH Combo also makes fertility testing more accessible for women, offering a non-invasive, efficient way to understand ovarian reserve and reproductive health with minimal effort and cost.

Problem:
While AMH (Anti-Müllerian Hormone) and FSH (Follicle Stimulating Hormone) tests are commonly used to assess ovarian reserve, the interpretation of these results can be unclear or insufficient for understanding a woman’s fertility potential, especially in cases of fluctuating hormonal levels or age-related decline.

Solution:

  • AMH/FSH Combo provides a more comprehensive view of female fertility by assessing two key hormones related to egg quality and ovarian health. This enables better understanding of reproductive potential, helping women make informed decisions about family planning or fertility treatments.

Problem:
Conventional medical tests often contribute to significant environmental waste and rely on non-sustainable materials.

Solution:

  • Both SpermoCheck Combo and the AMH/FSH Combo are developed with sustainable, bio-inert materials, reducing the environmental impact of fertility testing. These tests are designed to be efficient, eco-friendly, and easy to use, without sacrificing accuracy or reliability.

Problem:
Couples facing infertility may delay seeking treatment due to the complexity and cost of fertility tests, which can result in prolonged time-to-diagnosis and missed opportunities for earlier intervention.

Solution:

  • By offering quick, accessible, and precise testing, SpermoCheck Combo and AMH/FSH Combo reduce the time it takes for couples to get an accurate diagnosis, enabling them to explore treatment options more promptly and effectively. This helps reduce the emotional and financial strain that often comes with fertility issues.

In Summary, We Solve:

  • Fertility testing accessibility, making it easier and faster for both men and women to understand their reproductive health.
  • Uncertainty in male infertility diagnosis, providing a reliable, non-invasive way to distinguish between different types of male infertility.
  • The complexity of female fertility assessments, offering a clear view of ovarian reserve and hormonal balance.
  • Environmental impact in healthcare by using sustainable materials.
  • Delayed fertility diagnosis by providing rapid and actionable insights for timely decision-making.

With SpermoCheck Combo and AMH/FSH Combo, we are transforming fertility diagnostics, offering both men and women an opportunity to take charge of their reproductive health and make informed decisions.